<?xml version="1.0" encoding="UTF-8"?>
<ref id="B134-vaccines-07-00053">
 <label>134.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Sui</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Sheehan</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Hwang</surname>
    <given-names>W.C.</given-names>
   </name>
   <name>
    <surname>Bankston</surname>
    <given-names>L.A.</given-names>
   </name>
   <name>
    <surname>Burchett</surname>
    <given-names>S.K.</given-names>
   </name>
   <name>
    <surname>Huang</surname>
    <given-names>C.-Y.</given-names>
   </name>
   <name>
    <surname>Liddington</surname>
    <given-names>R.C.</given-names>
   </name>
   <name>
    <surname>Beigel</surname>
    <given-names>J.H.</given-names>
   </name>
   <name>
    <surname>Marasco</surname>
    <given-names>W.A.</given-names>
   </name>
  </person-group>
  <article-title>Wide prevalence of heterosubtypic broadly neutralizing human antiâ€“influenza A antibodies</article-title>
  <source>Clin. Infect. Dis.</source>
  <year>2011</year>
  <volume>52</volume>
  <fpage>1003</fpage>
  <lpage>1009</lpage>
  <pub-id pub-id-type="doi">10.1093/cid/cir121</pub-id>
  <?supplied-pmid 21460314?>
  <pub-id pub-id-type="pmid">21460314</pub-id>
 </element-citation>
</ref>
